CTLA4 and melanoma: To elucidate the mechanisms responsible for this effect, the authors of this study injected Trp1-specific CD4 T cells into mice that were challenged with a melanoma cell line, and showed that CTLA-4 inhibition increased both Trp1-specific Teff and Treg cell numbers, while reducing intratumoral accumulation of Trp1-specific Tregs rapidly by depletion.